MDM2 and systemic lupus erythematosus: Consistent with results reported in other studies, the frequency of anti-p53 positive sera was significantly higher in SLE patients group (39.50%) than NHS group (5.90%) (Figure 4), and the titer of anti-MDM2 was positively correlated with anti-p53 (Figure 5).